Edesa Biotech, Inc.

Historical 13F Holders

Symbol
EDSA
CUSIP
27966L306
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 27966L306 since 12/18/2024, largest first.

Filer % of Class Filed
Pardeep Nijhawan 13D/A
16.3% 8/25/2026
Event 8/21/2026
Velan Capital Investment Management LP 13D/A
10.0% 8/25/2026
Event 8/21/2026
Rubric Capital Management LP 13G
7.7% 5/15/2026
Event 3/31/2025
Sirenia Capital Management LP 13G
7.2% 5/15/2026
Event 3/31/2026
Stonepine Capital Management, LLC 13G
6.9% 8/26/2026
Event 8/20/2026
Perceptive Advisors LLC 13G
6.7% 3/16/2026
Event 3/9/2026
Integrated Core Strategies (US) LLC 13G
5.4% 6/18/2026
Event 6/11/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Point72 Asset Management, L.P. 13G/A
0% 5/15/2026
Event 3/31/2026
Nantahala Capital Management, LLC 13G/A
0% 5/15/2026
Event 3/31/2026
Thomas A. Satterfield, Jr. 13G/A 0% 2/18/2025
Event 2/13/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 33 3.75 M $31.0 M
2026 Q1 28 2.64 M $13.8 M
2025 Q4 22 3.05 M $4.34 M
2025 Q3 23 2.88 M $7.10 M
2025 Q2 22 2.11 M $4.28 M
2025 Q1 21 2.82 M $6.89 M
2024 Q4 18 208 k $350 k
2024 Q3 19 161 k $718 k
2024 Q2 19 151 k $645 k
2024 Q1 20 108 k $451 k
2023 Q4 21 111 k $507 k